Hoyue Capital

Hoyue Capital is a China-based healthcare-focused investment banking and financial advisory firm rather than a drug development company. The firm describes itself as a specialized healthcare industry investment bank serving medical and health enterprises with private financing, mergers and acquisitions, restructuring, and other capital markets solutions. Its sector coverage spans innovative therapeutics, innovative medical devices, IVD and life science tools, healthcare services, and digital health. In addition to advisory work, the broader organization also references an investment management business through a China healthcare industry fund. For biotech analysts, Hoyue Capital is best understood as a sector specialist advisor embedded in the Chinese healthcare ecosystem, not as an operating biotech with an internal therapeutic pipeline.